Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06168019 · ClinicalTrials.gov registry record
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
A clinical trial of COVID-19 and Influenza, sponsored by Boston University.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 2
- Study locations
NCT06168019 is a study of COVID-19 and Influenza that is actively recruiting participants, run by Boston University. The registered enrollment target is 10,000 participants, below the 55,165-participant average among 203 other COVID-19 trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06168019, a study of COVID-19 and Influenza, is actively recruiting participants, sponsored by Boston University.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the obstetric department delivers about 10,000 babies a year. The hypothesis is that co-infection of other respiratory viruses (ORV), particularly COVID-19 and Influenza increases the risk of adverse pregnancy outcomes in mothers and babies and could address the current standard of care in India to not vaccinate pregnant women during pregnancy, by either encouraging vaccination against both viruses before planning a pregnancy or during pregnancy based on global data supporting the safety of this strategy.
Conditions Studied
Interventions
- OTHER Exposures
Study Locations (2)
Massachusetts
- Boston University School of Public Health, Global Health - Boston
Other
- Government. Medical College Hospital - Nagpur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2023-12-26 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06168019
The ClinicalTrials.gov registry entry for NCT06168019 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,165-participant average among 203 other COVID-19 trials with a reported enrollment target (82% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Exposures is the first listed.
NCT06168019 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT06168019 about?
NCT06168019 is a clinical study titled "Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India". This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the obs...
What is the current status of trial NCT06168019?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2023-12-26. Estimated completion is 2028-06.
What conditions does trial NCT06168019 study?
This clinical trial studies the following conditions: COVID-19, Influenza, SARS CoV 2 Infection, Infant Morbidity, Other Respiratory Viruses.
What interventions are being tested in trial NCT06168019?
The interventions under investigation include: Exposures (OTHER).
Who is sponsoring clinical trial NCT06168019?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06168019 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.